Six papers
by Jerry L Campbell
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- MW Dzierlenga, M Moreau, G Song, P Mallick, PL Ward, JL Campbell, C Housand, M Yoon, BC Allen, HJ Clewell, and MP Longnecker. Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study. Environ Res 182 : 109017 (Mar 9, 2020). [abstract] [pubmed]
- KZ Travis, HJ Clewell, JL Campbell, and PM Hinderliter. Letter to the editor re: Cheng, YH., Chou, WC., Yang, YF. et al. Environ Sci Pollut Res (2017). https://doi.org/10.1007/s11356-017-0875-4. Environ Sci Pollut Res Int 25 (33) : 33832-33835 (Nov 6, 2018). [abstract] [pubmed]
- JL Campbell, M Yoon, PL Ward, H Fromme, W Kessler, MB Phillips, WA Anderson, HJ Clewell, and MP Longnecker. Excretion of Di-2-ethylhexyl phthalate (DEHP) metabolites in urine is related to body mass index because of higher energy intake in the overweight and obese. Environ Int 113 : 91-99 (Apr 6, 2018). [abstract] [pubmed]
- JL Campbell, ME Andersen, C Van Landingham, R Gentry, E Jensen, JY Domoradzki, and HJ Clewell. Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment. Toxicol Lett 279 Suppl 1 : 125-135 (Oct 20, 2017). [abstract] [pubmed]
- ME Andersen, MB Black, JL Campbell, SN Pendse, HJ Clewell, LH Pottenger, JS Bus, DE Dodd, DC Kemp, and PD McMullen. Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver. Toxicol Appl Pharmacol 332 : 149-158 (Oct 1, 2017). [abstract] [pubmed]